home.social

#neuronatherapeutics — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #neuronatherapeutics, aggregated by home.social.

fetched live
  1. Belgium @[email protected] ·

    Belgium: UCB completes acquisition of Neurona Therapeutics

    Euronext-listed UCB, a Belgium-based global biopharmaceutical company, has acquired Neurona Therapeutics, a US-based clinical-stage biotherapeutics company developing regenerative…
    #Belgium #BE #Europe #Europa #EU #België #belgien #Belgique #belgium #Nachrichten #NeuronaTherapeutics #Nieuws #Nouvelles #UCB
    europesays.com/3034294/

    #ucb #nouvelles #nieuws #neuronatherapeutics #nachrichten #belgique
  2. Belgium @[email protected] ·

    europesays.com/be/18603/ Belgium: UCB completes acquisition of Neurona Therapeutics #Belgium #NeuronaTherapeutics #UCB

    #ucb #neuronatherapeutics #belgium
  3. Industry Examiner @[email protected] ·

    UCB’s $1.15B Neurona Therapeutics acquisition is a high-stakes bet on cell therapy in epilepsy. The bigger question: can biotech move from suppressing seizures to repairing brain circuits?

    biotech.industryexaminer.com/u
    #Biotech #UCB #NeuronaTherapeutics #Epilepsy #CellTherapy #TechNews

    #biotech #ucb #neuronatherapeutics #epilepsy #celltherapy #technews
  4. Industry Examiner @[email protected] ·

    UCB’s $1.15B Neurona Therapeutics acquisition is a high-stakes bet on cell therapy in epilepsy. The bigger question: can biotech move from suppressing seizures to repairing brain circuits?

    biotech.industryexaminer.com/u
    #Biotech #UCB #NeuronaTherapeutics #Epilepsy #CellTherapy #TechNews

    #biotech #ucb #neuronatherapeutics #epilepsy #celltherapy #technews
  5. Industry Examiner @[email protected] ·

    UCB’s $1.15B Neurona Therapeutics acquisition is a high-stakes bet on cell therapy in epilepsy. The bigger question: can biotech move from suppressing seizures to repairing brain circuits?

    biotech.industryexaminer.com/u
    #Biotech #UCB #NeuronaTherapeutics #Epilepsy #CellTherapy #TechNews

    #biotech #ucb #neuronatherapeutics #epilepsy #celltherapy #technews
  6. Industry Examiner @[email protected] ·

    UCB’s $1.15B Neurona Therapeutics acquisition is a high-stakes bet on cell therapy in epilepsy. The bigger question: can biotech move from suppressing seizures to repairing brain circuits?

    biotech.industryexaminer.com/u
    #Biotech #UCB #NeuronaTherapeutics #Epilepsy #CellTherapy #TechNews

    #technews #celltherapy #epilepsy #neuronatherapeutics #ucb #biotech
  7. Industry Examiner @[email protected] ·

    UCB’s $1.15B Neurona Therapeutics acquisition is a high-stakes bet on cell therapy in epilepsy. The bigger question: can biotech move from suppressing seizures to repairing brain circuits?

    biotech.industryexaminer.com/u
    #Biotech #UCB #NeuronaTherapeutics #Epilepsy #CellTherapy #TechNews

    #biotech #ucb #neuronatherapeutics #epilepsy #celltherapy #technews